BioStar Ventures III-XF Overview
BioStar Ventures III-XF General Information
Description
BioStar Ventures III-XF is a 2018 vintage venture capital fund managed by BioStar Capital. The fund is located in Charlevoix, Michigan. The fund targets to invest in healthcare.
Contact Information
Fund Manager's Location
- 206 Bridge Street
- Charlevoix, MI 49720
- United States
BioStar Ventures III-XF Investments (8)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| REVA Medical | 09-Aug-2022 | Other Devices and Supplies | Profitable | |||
| Ablative Solutions | 13-Jun-2022 | Other Devices and Supplies | Clinical Trials - Phase 3 | |||
| Greenbrook TMS | 14-Jun-2021 | Clinics/Outpatient Services | Generating Revenue/Not Profitable | |||
| Senseonics | 11-Jan-2021 | Monitoring Equipment | Generating Revenue/Not Profitable | |||
| AVS (Surgical Devices) | 12-Jul-2020 | Surgical Devices | Generating Revenue | |||
| Olympic Ophthalmics | 08-Jan-2018 | Other Devices and Supplies | Generating Revenue | |||
| Corindus Vascular Robotics | 16-Mar-2017 | PIPE | Surgical Devices | Generating Revenue | ||
| TransMedics | 11-Jul-2016 | Later Stage VC (Series F) | Other Devices and Supplies | Profitable |
BioStar Ventures III-XF Investment Strategy
Investments by Industry
Investments by Deal Type
BioStar Ventures III-XF Limited Partners (1)
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| BioStar Capital | Current | 22-May-2019 | Original |
BioStar Ventures III-XF Team (5)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Louis Cannon MD | Founder & Senior Managing Director | Charlevoix, MI | |||
| Alan Davis MD | Managing Director | Charlevoix, MI | |||
| William Kucheman | Managing Director | Charlevoix, MI | |||
| Jeremy Touroo | Director | Charlevoix, MI | |||
| Mark Toland | Managing Director | Charlevoix, MI |
BioStar Ventures III-XF Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
BioStar Ventures III-XF Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
BioStar Ventures III-XF Benchmark (565)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Foundry.ai Fund I | |||||
| BioStar Ventures III-XF | 31-Dec-2023 | ||||
| Collab + Currency | 31-Mar-2024 | ||||
| LifeSci Venture Partners I | |||||
| BAM Ventures Partners II | |||||
| Wavemaker Partners V | |||||
| Yield Lab II | |||||
| LaunchTennessee Impact Fund | |||||
| New Ventures I | |||||
| EOS Global Fund |
BioStar Ventures III-XF FAQs
-
What is BioStar Ventures III-XF?
BioStar Ventures III-XF is a 2018 vintage venture capital fund managed by BioStar Capital.
-
Who manages BioStar Ventures III-XF?
BioStar Ventures III-XF is managed by BioStar Capital.
-
Where is BioStar Ventures III-XF domiciled?
BioStar Ventures III-XF is domiciled in United States: Delaware.
-
What is BioStar Ventures III-XF's size?
BioStar Ventures III-XF has a size of .
-
What type of fund is BioStar Ventures III-XF?
The fund type of BioStar Ventures III-XF is Venture.
-
What is the status of BioStar Ventures III-XF?
BioStar Ventures III-XF is closed.
-
What has BioStar Ventures III-XF invested in?
BioStar Ventures III-XF has made numerous investments in companies like REVA Medical, Ablative Solutions, and Greenbrook TMS within the Devices and Supplies and Clinics/Outpatient Services industries.
-
What has BioStar Ventures III-XF invested in recently?
BioStar Ventures III-XF's latest investment was on 09-Aug-2022 in REVA Medical, a company within the Devices and Supplies industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
